chemoendocrine

chemoendocrine

/che·mo·en·do·crine/ (-en´do-krin) chemohormonal.
Mentioned in ?
References in periodicals archive ?
22,60,61) The International Breast Cancer Study Group (IBCSG) conducted a series of studies comparing chemoendocrine therapy to endocrine therapy alone in years before the establishment of IHC testing.
Viale G, Regan MM, Maiorano E, et al: Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: Predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer.
Axillary lymph node scarring and the association with tumour response following neoadjuvant chemoendocrine therapy for breast cancer.
of Patients Intervention Reference (eligibility) (outcome) McCarty Pop A, n 5 62 Endocrine Rx et al (4) (early stage); (Pop C) Pop B, n 5 72 (early stage); Pop C, n 5 23 (MBC) Barnes 170 patients; First-line TAM et al (5) 74% ER in MBC (51% positive by response rate) LBA Harvey 1,982 patients 26% received et al (6) endocrine Rx and 13% received combined chemoendocrine Rx Elledge 205 patients SWOG 8228, TAM et al (7) with blocks 10 mg twice a (original n 5 day (n 5 56) or 349, all ER 10 mg/[m.
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.